|

Vincristin Clinical Trials

3 actively recruiting trials

▼ -1 trial since August 2026

Also known as: VCR; Vincrystine

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • The Lymphoma Academic Research Organisation1
  • Instituto do Cancer do Estado de São Paulo1
  • Institute of Hematology & Blood Diseases Hospital, China1

Indications

  • Cancer3
  • Gene Abnormality1
  • Acute Lymphoid Leukemia1
  • Chemotherapeutic Toxicity1
  • Minimal Residual Disease1

Other3 trials

Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil
R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Phase 1/2
Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.